Home » Authors » James Etheridge

Articles by James Etheridge

Transgene Licenses Technology To Merck On Nonexclusive Basis

Feb. 5, 2003

By James Etheridge

NicOx, Biolipox Expand Alliance To Areas Of Inflammation, Pain

Feb. 5, 2003

By James Etheridge

Rebif Sales Help Push Serono Over $1.5B In 2002 Revenues

Feb. 5, 2003

By James Etheridge

France Resuming Field Trials Of Genetically Modified Vines

Jan. 29, 2003

By James Etheridge

New French Law Would Allow Embryonic Stem Cell Research

Jan. 29, 2003

By James Etheridge

France Resuming Field Trials Of Genetically Modified Vines

Jan. 29, 2003

By James Etheridge

New French Law Would Allow Embryonic Stem Cell Research

Jan. 29, 2003

By James Etheridge

Adebag Planning Biotechnology Cluster In Southeastern France

Jan. 22, 2003

By James Etheridge

Second Complication Arises In French Gene Therapy Trial

Jan. 22, 2003

By James Etheridge

Cerep Collaborates With Pfizer On BioPrint Database, Software

Jan. 22, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.